April 30, 2024

Managing Partner Michael Abrams spoke with Axios about Bernie Sanders’ probe into the cost of Ozempic and Wegovy.

…right now, the world can’t get enough of these products. This would not be the moment to expect the manufacturer to start lowering the price.

Abrams also noted that private insurers aren’t likely to see a financial upside to covering the drugs.

Read the full story on axios.com